179 related articles for article (PubMed ID: 34872921)
1.
Peacock JG; Banks EA; McWhorter N
J Nucl Med Technol; 2022 Mar; 50(1):73-74. PubMed ID: 34872921
[TBL] [Abstract][Full Text] [Related]
2. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
3. 18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.
Wong FC; Martiniova L; Masrani A; Ravizzini GC
Clin Nucl Med; 2022 Feb; 47(2):154-155. PubMed ID: 34183501
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Ah-Thiane L; Ferrer L; Maucherat B; Fleury V; Le Thiec M; Rusu D; Rousseau C
Clin Nucl Med; 2022 Jul; 47(7):575-582. PubMed ID: 35675134
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
7. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
8. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.
Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G
Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762
[TBL] [Abstract][Full Text] [Related]
9. Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on
Notohamiprodjo S; Eiber M; Lohrmann C; Weber WA
J Nucl Med; 2022 Nov; 63(11):1673-1676. PubMed ID: 35241484
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.
Calabria F; Bagnato A; Guadagnino G; Toteda M; Lanzillotta A; Cardei S; Tavolaro R; Leporace M
Oncol Res; 2023; 31(2):117-124. PubMed ID: 37304242
[TBL] [Abstract][Full Text] [Related]
11. Morphological and Metabolic Criteria of COVID-19 Vaccine Associated Axillary Nodes on 18-Fluorodeouxyglucose PET/CT Imaging in Breast Cancer Patients.
Fatima N; Zaman U; Zaman A; Zaman S; Tahseen R; Zaman MU
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4053-4057. PubMed ID: 38156837
[TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG-Avid Lymph Nodes After COVID-19 Vaccination on 18F-FDG PET/CT.
Ulaner GA; Giuliano P
Clin Nucl Med; 2021 May; 46(5):433-434. PubMed ID: 33782318
[TBL] [Abstract][Full Text] [Related]
15. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
16.
Johnson BJ; Van Abel KM; Ma DJ; Johnson DR
J Nucl Med; 2021 Oct; 62(10):1483-1484. PubMed ID: 33741644
[No Abstract] [Full Text] [Related]
17. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
18. Axillary Lymph Node Uptake on
Otomi Y; Shinya T; Kasai H; Okada N; Matsushita T; Higashi K; Matsuzaki S; Hiroshima Y; Kubo M; Otsuka H; Harada M
Mol Imaging Radionucl Ther; 2023 Feb; 32(1):13-19. PubMed ID: 36817634
[TBL] [Abstract][Full Text] [Related]
19. Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.
Quak E; Morel A; Faudemer J; Levy C; Ciappuccini R
Clin Nucl Med; 2022 Mar; 47(3):275-276. PubMed ID: 34661560
[TBL] [Abstract][Full Text] [Related]
20. False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.
Nawwar AA; Searle J; Hopkins R; Lyburn ID
Clin Nucl Med; 2021 Dec; 46(12):1004-1005. PubMed ID: 33883486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
